Clinical trial
Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in…
NCT00003193 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00003193 |
|---|---|
| Title | Paclitaxel and Radiation Therapy Plus Chemoprotection With Amifostine in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | Phase I/II Study of Escalating Doses of Taxol Used Concurrently With Ethyol and Accelerated Hyperfractionated Radiotherapy in the Treatment of Stage III and IV Carcinoma of the Head and Neck |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer, Oral Complications |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | amifostine trihydrate, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 37 |
| Start date | Jan 1, 1998 |
| Primary completion | Sep 1, 2005 |
| Completion | Sep 1, 2005 |
| First posted | Apr 23, 2003 |
| Last update posted | Dec 6, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: